Chimeric antigen receptor macrophages activated through TLR4 or IFN-γ receptors suppress breast cancer growth by targeting VEGFR2
Cancer Immunology, Immunotherapy · 2023-10 · 72 (10) · 3243-3257
DOI: 10.1007/s00262-023-03490-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 12.07.2023. Verfasst von Zhaojun Duan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical Co…. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Neoplasms. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundamental Research Funds for the Central Universities, Bilateral Inter-Governmental S&T Cooperation Project from Ministry of Science and Technology of China, The Prospective Research Program of the Foundation for the Development of Frontier Technology of Cell Therapy of Changzhou Xitaihu.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China.
- Department of Immunology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, 100005, China. ypluo@ibms.pumc.edu.cn.
Förderung
- Fundamental Research Funds for the Central Universities
- Bilateral Inter-Governmental S&T Cooperation Project from Ministry of Science and Technology of China
- The Prospective Research Program of the Foundation for the Development of Frontier Technology of Cell Therapy of Changzhou Xitaihu
Zitieren
APA
Duan, Z., Li, Z., Wang, Z., Chen, C., & Luo, Y. (2023). Chimeric antigen receptor macrophages activated through TLR4 or IFN-γ receptors suppress breast cancer growth by targeting VEGFR2. Cancer Immunology, Immunotherapy, 72(10), 3243-3257. https://doi.org/10.1007/s00262-023-03490-8
Vancouver
Duan Z, Li Z, Wang Z, Chen C, Luo Y. Chimeric antigen receptor macrophages activated through TLR4 or IFN-γ receptors suppress breast cancer growth by targeting VEGFR2. Cancer Immunology, Immunotherapy. 2023;72(10):3243-3257. doi:10.1007/s00262-023-03490-8
BibTeX
@article{Duan2023,
author = {Duan, Zhaojun and Li, Zhen and Wang, Ziyuan and Chen, Chong and Luo, Yunping},
title = {Chimeric antigen receptor macrophages activated through TLR4 or IFN-γ receptors suppress breast cancer growth by targeting VEGFR2},
journal = {Cancer Immunology, Immunotherapy},
year = {2023},
volume = {72},
number = {10},
pages = {3243--3257},
doi = {10.1007/s00262-023-03490-8}
}
EUVIMED